Kenji Sugimoto

7.0k citations

175 papers · 5.6k indexed · 2 hit papers · h-index 35

Co-authors: Makoto Tachibana Yoichi Shinkai Tatsunobu Fukushima Hidetoshi Tokuyama Michio Himeno Naoki Takeda Hiroyuki Kato Jun Ueda
Topics: Microtubule and mitosis dynamics (21 papers)Synthetic Organic Chemistry Methods (21 papers)Genomics and Chromatin Dynamics (17 papers)
Cited by: Molecular Biology Cell Biology Organic Chemistry
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: Japan United States United Kingdom

In The Last Decade

Kenji Sugimoto

169 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis

2002 992 citations Makoto Tachibana, Kenji Sugimoto et al. profile →
SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3

2001 639 citations Makoto Tachibana, Kenji Sugimoto et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Kenji Sugimoto

Since Specialization

Citations

This map shows the geographic impact of Kenji Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Sugimoto more than expected).

Fields of papers citing papers by Kenji Sugimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Sugimoto. The network helps show where Kenji Sugimoto may publish in the future.

Co-authorship network of co-authors of Kenji Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Sugimoto. A scholar is included among the top collaborators of Kenji Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Sugimoto. Kenji Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Three‐Component Synthesis of Substituted Azepines by Gold/Magnesium Orthogonal‐Relay Catalysis 2024 ·Advanced Synthesis & Catalysis ·(unknown),(unknown),Kiyoshi Tsuge,Kenji Sugimoto,Yûji Matsuya	1
2	Controllable conformation and reactivity of bicyclic α-methylene cyclopentanones and their NF-κB pathway inhibitory activity 2023 ·Organic & Biomolecular Chemistry ·(unknown),(unknown),Yue Zhou,Masaru Tanioka,Kenji Sugimoto,Hiroaki Sakurai,Yûji Matsuya	1
3	Divinylcarbinol Desymmetrization Strategy: A Concise and Reliable Approach to Chiral Hydroxylated Fatty Acid Derivatives 2021 ·The Journal of Organic Chemistry ·Kenji Sugimoto,(unknown),(unknown),(unknown),Yûji Matsuya	2
4	Inhibition of gastric H+,K+-ATPase by new dihydropyrazole derivative KYY-008 2021 ·Biochemical and Biophysical Research Communications ·Takuto Fujii,Kenji Sugimoto,(unknown),Takahiro Shimizu,Yûji Matsuya,Hideki Sakai	3
5	Fluid shear stress applied by orbital shaking induces MG-63 osteosarcoma cells to activate ERK in two phases through distinct signaling pathways 2017 ·Biochemistry and Biophysics Reports ·Takashi Fukada,(unknown),Mito Kuroda,Noriyuki Kioka,Kenji Sugimoto	6
6	A Macrosphelide as the Unexpected Product of a Pleurotus ostreatus Strain-Mediated Biotransformation of Halolactones Containing the gem-Dimethylcyclohexane Ring. Part 1 2016 ·Molecules ·Katarzyna Wińska,Wanda Mączka,Małgorzata Grabarczyk,Kenji Sugimoto,Yûji Matsuya,Antoni Szumny,Mirosław Anioł	3
7	In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5′-methylful-3′-yl)propane-1,2,3-triol 2016 ·Journal of Natural Medicines ·Kohei Sasaki,Kyoko Hayashi,Yûji Matsuya,Kenji Sugimoto,Jung‐Bum Lee,Fumiya Kurosaki,Toshimitsu Hayashi	6
8	Enantiocontrolled Total Synthesis of (−)‐Mersicarpine 2013 ·Chemistry - A European Journal ·Yusuke Iwama,Kentaro Okano,Kenji Sugimoto,Hidetoshi Tokuyama	46
9	Synthesis and structure–activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo–keto reductase (AKR) 1B10 2013 ·Bioorganic & Medicinal Chemistry ·Satoshi Endo,(unknown),(unknown),Toshiyuki Matsunaga,Kenji Sugimoto,Yûji Matsuya,Ossama El‐Kabbani,Kazuo Kuwata,Akira Hara,Yukio Kitade,Naoki Toyooka	25
10	Identification of Novel Nuclear Protein Interactions with the N-Terminal Part of Filamin A 2011 ·Bioscience Biotechnology and Biochemistry ·Hao Qiu,(unknown),(unknown),Takashi Fukada,Kenji Sugimoto	3
11	Visualization of Aberrant Perinuclear Microtubule Aster Organization by Microtubule-Destabilizing Agents 2009 ·Bioscience Biotechnology and Biochemistry ·(unknown),(unknown),Shigenori Oka,Kenji Sugimoto	4
12	Differential responses of mitotic spindle pole formation to microtubule-stabilizing agents epothilones A and B at low concentrations 2008 ·Cell Cycle ·(unknown),(unknown),Takashi Fukada,(unknown),Shigenori Oka,Kenji Sugimoto	18
13	Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d ]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells 2008 ·Drug Metabolism and Disposition ·Tsuyoshi Minematsu,(unknown),Kenji Sugimoto,Nobuaki Shirai,Takahito Nakahara,Takashi Usui,Hidetaka Kamimura	27
14	Amyloid-forming propensity of the hydrophobic non-natural amino acid on the fibril-forming core peptide of human tau 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Kenji Sugimoto,Takashi Konno,Takashi Morii	11
15	Three distinct stages of apoptotic nuclear condensation revealed by time-lapse imaging, biochemical and electron microscopy analysis of cell-free apoptosis 2007 ·Experimental Cell Research ·Shigenobu Toné,Kenji Sugimoto,(unknown),Taiji Suda,Kenzo Uehira,Hiroaki Kanouchi,Kumiko Samejima,Yohsuke Minatogawa,William C. Earnshaw	161
16	Syntheses of α-arbutin-α-glycosides and their inhibitory effects on human tyrosinase 2005 ·Journal of Bioscience and Bioengineering ·Kazuhisa Sugimoto,Koji Nomura,Takahisa Nishimura,Taro Kiso,Kenji Sugimoto,Takashi Kuriki	61
17	SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3breakdown → 2001 ·Journal of Biological Chemistry ·Makoto Tachibana,Kenji Sugimoto,Tatsunobu Fukushima,Yoichi Shinkai	639
18	A nuclear factor NF-GM2 that interacts with a regulatory region of the GM-CSF gene essential for its induction in response to T-cell activation: purification from human T-cell leukemia line Jurkat cells and similarity to NF-_χB 1991 ·International Immunology ·Akio Tsuboi,Kenji Sugimoto,Junji Yodoi,Shoichiro Miyatake,Ken‐ichi Arai,(unknown)	22
19	Alphoid satellite DNA is tightly associated with centromere antigens in human chromosomes throughout the cell cycle 1989 ·Experimental Cell Research ·Hiroshi Masumoto,Kenji Sugimoto,Tuneko Okazaki	94
20	Three Cases of Adult T Cell Leukemia 1980 ·The Nishinihon Journal of Dermatology ·Kenji Sugimoto,Yoko Nakano,Masayuki Shimizu,Yasuo Nakamura,(unknown)	1

About Kenji Sugimoto

Kenji Sugimoto is a scholar working on Organic Chemistry, Cell Biology and Pharmacology, having authored 175 papers that have together received 5.6k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (21 papers), Synthetic Organic Chemistry Methods (21 papers) and Genomics and Chromatin Dynamics (17 papers). The work is most often cited by research in Molecular Biology (3.6k citations), Cell Biology (799 citations) and Organic Chemistry (1.1k citations). Kenji Sugimoto has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Makoto Tachibana, Yoichi Shinkai, Tatsunobu Fukushima, Hidetoshi Tokuyama, Michio Himeno, Naoki Takeda, Hiroyuki Kato, Jun Ueda, Tsutomu Ohta and Hiroyuki Niida. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact